Veterinary medicines European public assessment report (EPAR): Suvaxyn Circo+MH RTU, porcine circovirus and porcine enzootic pneumonia vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Suvaxyn Circo+MH RTU, porcine circovirus and porcine enzootic pneumonia vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Suiseng Diff/A, clostridioides difficile,clostridium perfringens vaccine, inactivated, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Suiseng Diff/A, clostridioides difficile,clostridium perfringens vaccine, inactivated, Status: Authorised

Human medicines European public assessment report (EPAR): Orserdu, elacestrant, Date of authorisation: 15/09/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Orserdu, elacestrant, Date of authorisation: 15/09/2023, Revision: 4, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Rabitec, rabies vaccine (live, oral) for foxes and raccoon dogs, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Rabitec, rabies vaccine (live, oral) for foxes and raccoon dogs, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Isturisa, osilodrostat, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrine disorders, PIP number: P/0325/2024

Opinion/decision on a Paediatric investigation plan (PIP): Isturisa, osilodrostat, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrine disorders, PIP number: P/0325/2024

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness